Lamivudine monotherapy in an HIV-infected patient with the M184V mutation.
Chan-Tack
Kirk Maurice
KM
Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, UMBI, N540, Baltimore, MD 21201, USA. kchan@medicine.umaryland.edu
Edozien
Anthony
A
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1 / Q000235:genetics*; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy; D006801:Humans; D015228:Hypertriglyceridemia / Q000150:complications / Q000188:drug therapy; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D019380:Anti-HIV Agents; D019259:Lamivudine